7
2021Langland
AGENCY STATEMENT
Langland, a Publicis Health Company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy & Education, Public Relations & Policy and Advertising, to create unique value with visionary clients.

- Agency description
About Langland
The health universe is messy and prone to misunderstanding. We are structured to bring it together.
To us, health communications is not a set of siloed activities, or a linear journey with a beginning and an end. It’s a universe, a constant cycle where science becomes treatments, treatments become brands, brands become life-saving experiences. Yet through this cycle medical literacy degrades, messages get misinterpreted, and people are misunderstood.
By bringing together four key health disciplines, centred around four essential crafts, we Think Further. Embracing the power of different perspectives to help people make sense of science, and science make sense of people, creating healthier futures together.
Our disciplines
Each discipline is powered to deliver alone or together, and create unique value with visionary clients.
- Clinical Trial Experience
- Medical Strategy & Education
- Public Relations & Policy
- Advertising
Our crafts- Science
- Strategy
- Creative
- Production
Our valuesAnd importantly, we hold ourselves to our values:
- Imagination - Pushing the boundaries of creativity and originality.
- Discipline – Intellectual rigour and respect for the laws of science.
- Togetherness - Kindness and admiration for our fellow citizens.
- Contact details
- 2 Television Centre, 101 Wood Lane, London, W12 9RF
- 442074211771
- thinkfurther@publicislangland.com
- https://publicislangland.com/
- Key contact
- Victoria Wright
- Group Managing Director
- victoria.wright@publicislangland.com
- 2021 Agency Data
-
2020 awardsTotal staff250-499 staffBillings from UK creative healthcare workHealthcare staff150 - 249 staffTotal agency billingsAgency ageOver 30 yearsSocial media footprintStatusNETWORKEDApproximate percentage of advertising, branding, creative or design work in the UK healthcare market20-29%
- This information was supplied or confirmed by Langland. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- Awards
- Cannes Lions Pharma 2020/21 - INTEGRATED CAMPAIGN -BREAKING DEPRESSION - BRONZE LION
Creative Floor Healthcare Awards 2020/21 - HCPs: EXHIBITION and HCPs: MIXED MEDIA - BREAKING DEPRESSION
Communiqué 2020 - EXCELLENCE IN MULTICHANNEL COMMUNICATIONS and EXCELLENCE IN COMMUNICATION THROUGH CREATIVE EXECUTION - BREAKING DEPRESSION
PM360 Trailblazer Awards – Gold: Sales Aid
LIA – Silver: Pharma & Medical: Education and Services – Breaking Depression
PharmaTimes Aspiring Communications Manager of the Year
PharmaTimes Medical Affairs Communications Manager of the Year
PharmaTimes Medical Affairs Communications Team of the Year - This may contain additional awards supplied by Langland that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
Latest content from Langland on PMHub
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the session and bringing in broader perspectives from across the Langland team. In our MedComms Networking webinar last month (https://lnkd.in/dN5tHkf), Drew Owen, Diane Ross and I reviewed communications throughout the COVID pandemic to discuss what we felt they taught us about good healthcare communications practice
Langland - LANGLAND WELCOMES MIKE BRIGHTLEY TO ITS ADVERTISING TEAM
Langland- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked, it can lead to a negative build-up of emotion that could be counter-productive to the original intent. Here we discuss fear and encouragement as communication tactics.
Langland



COVID-19 Updates and Daily News
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
Quick links
Latest intelligence
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Moderna to launch Innovation and Technology Center in the UK
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
Origins Insights
Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...